Reuters logo
BRIEF-Windtree Therapeutics Q1 operating loss $8.1 million
May 15, 2017 / 8:20 PM / 4 months ago

BRIEF-Windtree Therapeutics Q1 operating loss $8.1 million

May 15 (Reuters) - Windtree Therapeutics Inc

* Windtree Therapeutics reports first quarter 2017 financial results and provides key business updates

* For quarter ended march 31, 2017, company reported an operating loss of $8.1 million, compared to $13.9 million for Q1 of 2016

* Grant revenue for Q1 of 2017 was $0.2 million compared to $0.1 million for Q1 of 2016

* Anticipates that it has sufficient cash to support operations through planned completion of aerosurf phase 2b clinical trial Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below